Large bowel cancer

Chapter 24 Large bowel cancer



Introduction



Bowel cancer screening


Colorectal cancer (CRC) is one of the most common forms of cancers in the Western world. Lifetime risk to age 75 in the general population is 1:17 for men and 1:26 for women in Australia and is the second leading cause of death.1


Research shows that the risk of developing bowel cancer rises significantly from the age of 50 and accounts for 85% of sporadic cancers.2


Most cancers of the bowel arise from polyps (adenomas) and removal of polyps markedly reduces the subsequent risk of disease.3


Various countries are in the process of introducing national screening programs, and in Australia a population of greater risk are invited to take part in the program.1


The eligible population in Australia is those turning 50, 55 and 65 years of age between January 2008 and 31 December 2010. In the US, screening will commence at a similar age (50).4 People eligible to participate in the program will receive an invitation through the mail to complete a faecal occult blood test (FOBT) and no cost is involved. There is controversy as to which is the best screening method and also which is the best FOBT.2,5,6 In the US, FOBT will also be used.


There is also increasing evidence to support the use of virtual colonoscopy as an initial screening test.7


If the FOBT is positive, the participant will be advised to discuss the result with their doctor who will generally refer them for a colonoscopy.4 Doing an FOBT every 2 years can reduce the risk of dying from bowel cancer by up to one-third.2


High-risk patients such as those with familial adenomatous polyposis and hereditary non-polyposis CRC need to be screened more frequently. As with all other screening tests, there needs to be an emphasis on combining screening with prevention, in particular with CRC where there is considerable research data on prevention.8







Nutritional influences



Diet



Excess energy intake/fat and carbohydrates


Execss energy intake has been shown to be consistently associated with bowel cancer.20


Fat intake is closely associated with energy intake, it has been difficult to differentiate between the two, to add to this confusion a meta-analysis found little evidence of any energy-independent effect of either total or saturated fat.21


Several prospective, observational studies have shown that diet is a major factor in the aetiology of large bowel cancer, with high fish consumption highlighted as decreasing CRC risk. A problem with most of the older studies has been that fats, such as those from fish fats which have been shown to be protective in more recent studies, were not differentiated from other fats.22, 23


A recent randomised clinical trial (RCT) objectively investigated the effects of a 6-month intervention with oil-rich or lean fish versus dietary advice only, on apoptosis and mitosis within the colonic crypt. The participants had either colorectal polyps, inactive ulcerative colitis, or no macroscopic signs of disease.24 The results of the trial showed that the total number of mitotic cells per crypt decreased non-significantly in the salmon group and in the cod group compared with the dietary-advice-only group. The study concluded that an increase in the consumption of either oil-rich or lean fish to 2 portions weekly over 6-months did not markedly change apoptotic and mitotic rates in the colonic mucosa. Moreover it should be noted that fish fats consumption may be a lifetime strategy, not just a short-term solution. A recent review unequivocally concludes that intake of fish fats has a favourable effect on lowering cancer risk.25


High consumption of trans-fatty acids is linked to colorectal adenomas.26


There is confusion as to whether carbohydrate intake can influence CRC, but it would be very unlikely that refined carbohydrates were not a risk factor.27, 28








Nutritional supplements



Micronutrients







Probiotics/prebiotics


Probiotics and prebiotics are likely to be protective, in particular as they greatly influence the internal bowel environment.48


A number of studies demonstrate that probiotics alter bowel microflora and decrease premalignant and malignant lesions in laboratory experiments in animal studies.49, 50


Radiation enteritis is a severe problem in patients receiving irradiation of the abdomen or pelvis in the course of cancer treatment. Experimental studies in animal models and clinical trials of patients with inflammatory bowel disease (IBD) have consistently shown that the use of probiotic organisms may effectively down-modulate the severity of intestinal inflammation by altering the composition and metabolic and functional properties of indigenous flora of the gut.51 Recently a multi-centre randomised study demonstrated that nutritional intervention with the probiotic drink containing L. casei DN-114 001 does not reduce the incidence of radiation-induced diarrhoea as defined by a Common Toxicity Criteria Grade 2 or greater. However, it had a significant effect on stool consistency as measured by the Bristol scale.52 However an earlier study with 490 patients who underwent adjuvant postoperative radiation therapy after surgery for sigmoid, rectal, or cervical cancer and who were assigned to either the high-potency probiotic preparation VSL#3 (one sachet 3 times a day [tid]) or placebo starting from the first day of radiation therapy showed that with a multi-strain preparation it protected cancer patients against the risk of radiation-induced diarrhoea.53



Phytonutrients


There are several naturally occurring compounds on foods of plant origin (vegetables, fruit, cereals and tea) that have strong protective effects against CRC in addition to their protection from their fibre content.54, 55 Of particular interest are the cruciferous vegetables, onion family, leafy vegetables, tomatoes, as well as fruits and cereals containing carotenoids, vitamin C and E.46 Phytonutrients include carotenoids, vitamin C, vitamin E, folate, indoles, allylic sulphides and lycopene.




Vitamins E and C


Several dietary antioxidants such as tea polyphenols, curcumin, genistein, resveratrol, lycopene, pomegranate and lupeol can re-stabilise and modulate cellular metabolic function. A case-control study from Melbourne (Australia) found that dietary micronutrients involved in DNA methylation (folate, methionine and vitamins B6 and B12) and some of those with antioxidant properties (selenium and vitamins E and C) may have a role to play in lowering colorectal cancer risk.59


Stone and Papas highlight the difference between alpha-tocopherol and gamma-tocopherol, and that the latter may be more protective.60


Gamma-tocopherol is a major form of vitamin E in Western diets and has found to be an anti-inflammatory agent plus directly inhibits cyclooygenase-2 (COX-2) activity and this may be another way in which it could be protective.61 These authors highlight the important difference between the synthetic dl-alpha-tocopherol acetate and the natural form.


An earlier meta-analysis of 5 prospective nested, case-control studies indicated that high serum levels of alpha-tocopherol were associated with a modest decrease in subsequent incidence of CRC.62 A more recent study, the large Nurses Health Study, found that 300IU/day of supplemented vitamin E mainly protects CRC in men but not in women.63 A population-based control study of patients with rectal cancer from the US showed that vitamin E and lycopene may reduce the risk of rectal cancer.64


More recently, in 4 major trials involving beta-carotene, vitamin C and synthetic alpha- tocopherol vitamin E, or vitamin C and E or beta-carotene, and vitamin C and E, the latter study involved those with familial adenomatous polyposis. All studies showed no benefit.6568


All of these latter studies supplemented with the synthetic form of alpha-tocopherol, and also did not use gamma-tocopherol.

Stay updated, free articles. Join our Telegram channel

Dec 4, 2016 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Large bowel cancer

Full access? Get Clinical Tree

Get Clinical Tree app for offline access